Can Fite Biopharma
CANF
#9760
Rank
A$19.52 M
Marketcap
$3.02
Share price
-1.99%
Change (1 day)
-7.36%
Change (1 year)

Earnings for Can Fite Biopharma (CANF)

Earnings in 2023 (TTM): -A$11.49 Million

According to Can Fite Biopharma 's latest financial reports the company's current earnings are A$0.74 Million. , an increase over its 2022 earnings that were of -A$15.61 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Can Fite Biopharma from 2011 to 2023

Annual earnings

Year Earnings Change
2023 -A$11.72 Million-24.96%
2022 -A$15.61 Million-19.36%
2021 -A$19.36 Million-12.66%
2020 -A$22.16 Million50.65%
2019 -A$14.71 Million45.99%
2018 -A$10.08 Million20.87%
2017 -A$8.34 Million-22.3%
2016 -A$10.73 Million38.19%
2015 -A$7.77 Million-19.58%
2014 -A$9.66 Million-28.12%
2013 -A$13.44 Million-35.99%
2012 -A$20.99 Million133.95%
2011 -A$8.97 Million